Milestone Pharmaceuticals Inc (MIST)
1.69
+0.05
(+3.05%)
USD |
NASDAQ |
May 03, 16:00
1.67
-0.02
(-1.18%)
After-Hours: 20:00
Milestone Pharmaceuticals Price to Book Value: 5.356 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 5.356 |
| May 02, 2024 | 5.197 |
| May 01, 2024 | 5.071 |
| April 30, 2024 | 5.229 |
| April 29, 2024 | 4.976 |
| April 26, 2024 | 4.880 |
| April 25, 2024 | 5.007 |
| April 24, 2024 | 5.261 |
| April 23, 2024 | 5.388 |
| April 22, 2024 | 5.166 |
| April 19, 2024 | 5.197 |
| April 18, 2024 | 5.166 |
| April 17, 2024 | 5.546 |
| April 16, 2024 | 5.578 |
| April 15, 2024 | 5.562 |
| April 12, 2024 | 5.483 |
| April 11, 2024 | 5.372 |
| April 10, 2024 | 5.292 |
| April 09, 2024 | 5.292 |
| April 08, 2024 | 5.768 |
| April 05, 2024 | 5.704 |
| April 04, 2024 | 5.546 |
| April 03, 2024 | 5.578 |
| April 02, 2024 | 5.704 |
| April 01, 2024 | 5.800 |
| Date | Value |
|---|---|
| March 28, 2024 | 5.673 |
| March 27, 2024 | 5.704 |
| March 26, 2024 | 5.736 |
| March 25, 2024 | 5.483 |
| March 22, 2024 | 5.514 |
| March 21, 2024 | 4.944 |
| March 20, 2024 | 4.754 |
| March 19, 2024 | 4.595 |
| March 18, 2024 | 4.722 |
| March 15, 2024 | 4.595 |
| March 14, 2024 | 4.500 |
| March 13, 2024 | 4.595 |
| March 12, 2024 | 4.706 |
| March 11, 2024 | 4.880 |
| March 08, 2024 | 4.785 |
| March 07, 2024 | 4.754 |
| March 06, 2024 | 4.595 |
| March 05, 2024 | 5.007 |
| March 04, 2024 | 4.912 |
| March 01, 2024 | 3.214 |
| February 29, 2024 | 3.354 |
| February 28, 2024 | 4.252 |
| February 27, 2024 | 4.392 |
| February 26, 2024 | 4.213 |
| February 23, 2024 | 3.394 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3633
Minimum
Mar 24 2020
5.800
Maximum
Apr 01 2024
2.299
Average
2.079
Median
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4302 |
| Aurinia Pharmaceuticals Inc | 1.930 |
| Edesa Biotech Inc | 2.514 |
| Lexaria Bioscience Corp | 6.185 |
| Xenon Pharmaceuticals Inc | 3.558 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0375 |
| Price | 1.69 |
| Earnings Yield | -82.25% |
| Market Cap | 89.82M |
| PEGY Ratio | -0.0375 |